Page 10 - Secondary Progressive Multiple Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tiziana Life Sciences (TLSA) Updated Interim Results for the Six Months Ended 30 June 2022

Tiziana Life Sciences (TLSA) Updated Interim Results for the Six Months Ended 30 June 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKunwar shailubhaiThomas adamsMatthew davisGabriele cerroneTanuja chitnisPatient expanded access programPatient population expanded access programGood laboratory practiceAccess ea programTiziana life sciences ltdLife sciences ltdSecondary progressive multiple sclerosisIndividual patient expanded access programHealthy subjectsExpanded disability status scale

Tiziana Life Sciences Ltd : Tiziana Life Sciences Ltd (Tiziana or the Company) - Updated Interim Results for the Six Months Ended 30 June 2022

LONDON, Dec. 29, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd ("Tiziana", NASDAQ: TLSA), a biotechnology company enabling breakthrough CNS immunomodulation approaches to enhance the functionality

United statesCity ofUnited kingdomKunwar shailubhaiIrina kofflerThomas adamsMatthew davisHana malikGabriele cerroneTanuja chitnisLifesci advisorsPatient population expanded access programGood laboratory practiceTiziana life sciencesPatient expanded access programTiziana life sciences ltd

Tiziana Life Sciences Ltd ( Tiziana or the Company ) - Updated Interim Results for the Six Months Ended 30 June 2022

Tiziana Life Sciences Ltd ( Tiziana or the Company ) - Updated Interim Results for the Six Months Ended 30 June 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomKunwar shailubhaiThomas adamsMatthew davisHana malikGabriele cerroneTanuja chitnisPatient population expanded access programGood laboratory practiceIrina kofflerlifesci advisorsTiziana life sciencesPatient expanded access programTiziana life sciences ltdAccess ea program

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomKunwar shailubhaiIrina kofflerThomas adamsMatthew davisHana malikGabriele cerroneTanuja chitnisLifesci advisorsPatient population expanded access programGood laboratory practiceTiziana life sciencesPatient expanded access programTiziana life sciences ltd

Tiziana Life Sciences Ltd ups R&D spend in first half of 2022 as it advances its next-generation therapeutics

Tiziana Life Sciences Ltd ups R&D spend in first half of 2022 as it advances its next-generation therapeutics
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Tiziana life sciencesTiziana life sciences ltdDrug administrationPatient expanded access ea programSecondary progressive multiple sclerosisIndividual patient expanded accessLife sciences